In this study, we demonstrated that GPR4 increased intestinal inflammation in DSS chronic colitis and AOM/DSS colitis-associated colorectal cancer mouse models (Figure 1, Figure 2, Figure 3 and Figure 4). Here, GPR4 is linked to colitis.